This product is not a drug, food, or cosmetic and is not intended for human or veterinary use, diagnosis, or therapeutic application
How the MHRA Assesses a Product MHRA guidance explains that a product may be a medicine when it is presented as treating or preventing disease
Research investigations demonstrate FOXO4-DRI's capacity to restore tissue homeostasis across multiple organ systems, providing researchers with tools for studying the causal relationships between senescent cell burden and age-related functional decline
Unapproved peptides, such as Retatrutide, have not been assessed by the TGA for safety, quality or effectiveness
Through its ability to neutralize harmful free radicals, support liver function, and enhance cellular health, glutathione has the potential to prevent and alleviate a wide range of health conditions